BURLINGTON, Mass., May 22, 2025 /PRNewswire/ — Clymb Clinical is proud to announce the launch of TFL Viewer, a state-of-the-art SaaS application designed to streamline the review, feedback, and approval process for Tables, Figures, and Listings (TFLs) in clinical trials. Built for Biotechnology, Pharmaceutical, Medical Device, and CRO companies, TFL Viewer enhances collaboration, efficiency, and accuracy in clinical reporting, ensuring seamless regulatory submission workflows.
“The launch of our TFL Viewer expands our TFL automation suite, adding another powerful solution to streamline development and review” said Co-Founder, Bhavin Busa. “Our TFL Viewer cuts through the clutter – no more messy reviews, scattered files, or complicated submissions. Just smooth collaboration, clear feedback, and easy access to your clinical trial results in one place.”
Co-Founder Colin Izzo added, “We have been amazed at the feedback we have received from our Clients and Community Users of TFL Designer which allows users to automate the design and generation of TFL Shells. Now, with our launch of TFL Viewer, we can further TFL Automation to include Clinical Development, Medical Monitors, Data Management, Regulatory and Medical Writing teams as well as Biostatistics – all within a centralized platform.”
Clymb’s Head of IT & Software Engineering, Navin Dedhia, emphasized the importance of innovation in clinical trial analysis and reporting: “We firmly believe that by consolidating TFLs into a unified platform which contains intuitive automation and AI-driven content generation, Clinical Study teams will be able to enhance the quality of Analysis Results and accelerate Clinical Study Report (CSR) Generation.”
About Clymb Clinical
Clymb Clinical is a clinical data services company leveraging technology-driven solutions to optimize biostatistics, regulatory submissions, and clinical trial reporting. With a mission to innovate, integrate, and improve, Clymb Clinical provides scalable, cost-effective solutions to biotechnology and pharmaceutical companies worldwide.
To learn more about Clymb Clinical and explore TFL Viewer, visit TFL Viewer | Streamline Clinical Trial Data Review or follow Clymb Clinical on LinkedIn for updates.
SOURCE Clymb Clinical
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…